Catalyst Wire Dossier Catalyst Wire Dossier

Telitacicept

· RemeGen Co., Ltd.
Drug timelines are a Plus or Pro feature.

47 regulatory and trial events tracked for Telitacicept, covering 2023-02-24 to 2026-04-20. Get the full timeline:

Most recent: Clinical Trial Update: Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease [Phase 3]

See pricing